Xu Yuan bought FATE

June 12, 2026 · Form 4 insider transaction

Xu Yuan bought 87,900 shares of Fate Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Acquired (buy-side)
Shares
87,900
Price
$0.00
Total value
N/A
InsiderXu Yuan
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 12, 2026
Filing dateJune 15, 2026
Shares owned after87,900
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's Annual Meeting of Stockholders.; The shares subject to this option shall vest and become exercisable on the earlier of (i) June 12, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.

View the original Form 4 on SEC EDGAR